FDA action counts
| Total FDA actions | 8 |
|---|---|
| Warning letters | 0 |
| Recalls | 8 |
| Approval records | 0 |
| Form 483 inspection citations | 0 |
| Most recent action | September 9, 2026 |
Risk pattern analysis
Argus HQ analysis — not an FDA finding
This section is Argus HQ analysis, not an FDA finding. Fresenius Medical Care Renal Therapies Group, LLC has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Enforcement history
On 2026-09-02, Argus HQ recorded an FDA recall for Fresenius Medical Care Renal Therapies Group, LLC, rated "high" severity in Argus HQ's classification: Fresenius Medical Care Renal Therapies Group, LLC — Class II recall: Fresenius Medical Care, 2008T BlueStar Hemodialysis Machine, Model Numbers: 191…. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.
Frequently asked questions
- Does Argus HQ track new FDA actions for Fresenius Medical Care Renal Therapies Group, LLC automatically?
- Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Fresenius Medical Care Renal Therapies Group, LLC is observed, this page's event count and history update automatically.
- How many FDA actions does Argus HQ track for Fresenius Medical Care Renal Therapies Group, LLC?
- 8 total: 0 warning letters, 8 recalls, 0 approval records, and 0 Form 483 inspection citations.
- What is the most recent FDA action on file for Fresenius Medical Care Renal Therapies Group, LLC?
- September 9, 2026. Argus HQ ingests new FDA enforcement records daily.
- Has Fresenius Medical Care Renal Therapies Group, LLC had product recalls?
- Yes, 8 recalls on file. See the full history below for each one.
Every FDA action tied to this company, the week it happens.
Free weekly briefing. Real-time alerts on paid plans.
Related enforcement actions
- Fresenius Medical Care Renal Therapies Group, LLC — Class II recall: 5008X HD/HDF Standard Blood Tubing Set Part Number 03-5300-3 →
- Fresenius Medical Care Renal Therapies Group, LLC — Class II recall: 5008X HD/HDF with CLiC Blood Tubing Set Part number 03-5300-3C →
- Fresenius Medical Care Renal Therapies Group, LLC — Class II recall: 5008X HD/HDF with Twister Blood Tubing Set Part Number 03-5350-8 →
- Fresenius Medical Care Renal Therapies Group, LLC — Class II recall: Citrasate, Liquid Acid Concentrate for Bicarbonate Hemodialysis: Product Number… →
- Fresenius Medical Care Renal Therapies Group, LLC — Class II recall: NaturaLyte, Liquid Acid Concentrate for Bicarbonate Hemodialysis: Product Numbe… →
- Fresenius Medical Care Renal Therapies Group, LLC — Class II recall: GRANUFLO Dry Acid Concentrate: Product Numbers: 0FD2251-3B; 0FD3251-3B; Dry Ac… →
- Fresenius Medical Care Renal Therapies Group, LLC — Class II recall: 5008X Standard HD Pre-Flush Standard Blood Tubing Set Part Number 03-5110-… →
- Fresenius Medical Care Renal Therapies Group, LLC — Class II recall: Fresenius Medical Care, 2008T BlueStar Hemodialysis Machine, Model Numbers: 191… →
Compare with
- Fresenius Medical Care Renal Therapies Group, LLC vs Philips North America
- Fresenius Medical Care Renal Therapies Group, LLC vs Medline Industries, LP
- Fresenius Medical Care Renal Therapies Group, LLC vs Boston Scientific Corporation
- Fresenius Medical Care Renal Therapies Group, LLC vs Baxter Healthcare Corporation
- Fresenius Medical Care Renal Therapies Group, LLC vs PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Verified from FDA.gov · Last updated: Sep 9, 2026Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). FDA Actions Against Fresenius Medical Care Renal Therapies Group, LLC. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/company/fresenius-medical-care-renal-therapies-group-llc
"FDA Actions Against Fresenius Medical Care Renal Therapies Group, LLC." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/company/fresenius-medical-care-renal-therapies-group-llc.
Argus HQ Research. "FDA Actions Against Fresenius Medical Care Renal Therapies Group, LLC." Digital Empire Holdings LLC. Accessed September 15, 2026. https://argushq.ai/company/fresenius-medical-care-renal-therapies-group-llc.
@misc{argushq_argushq_ai_company_fresenius_medical_care_renal_therapies_group_llc_2026,
title = {FDA Actions Against Fresenius Medical Care Renal Therapies Group, LLC},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/company/fresenius-medical-care-renal-therapies-group-llc},
note = {Accessed: September 15, 2026}
}Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗

